Pfizer’s announcement that it will stop developing its oral weight-loss drug gave shares of Wegovy maker Novo Nordisk and ...

A study found that medicines marketed as Zepbound and Mounjaro can help people lose weight for up to three years.

Patients regularly taking Eli Lilly & Co.’s obesity shot Zepbound tend to keep the weight off for at least three years, with ...

Ryan Rasmussen was determined to lose weight so he would be around to ski and spend time with his wife and children.

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

Lilly said it would report data from another trial for the pill for weight management later in the year. It plans to file for ...

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...

I n an hour-long meeting at Eli Lilly and Company’s headquarters in Indianapolis on April 15, the pharmaceutical company’s top executives met, like they had dozens of times before, to hear the ...

The pharmaceuticals company says a trial of the pill showed it was similarly safe to injectable weight-loss drugs.

Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and ...

Ohio Attorney General Dave Yost issued a warning to several Ohio medical spas over their alleged claims regarding weight-loss drugs.

Shares of weight-loss drugmakers Novo Nordisk A/S and Eli Lilly and Co. got a nice lift Monday, after a potential competitor decided to cancel development of its GLP-1 obesity drug. “We continue ...